Thirdly, clinical markers that may affect bone metastasis of cancer, including BRAF mutation, calcitonin, TERT mutation, and Ki-67 index, were not included in this study (9, 47, 48), and we will continue to expand our data collection to further improve our model in the future. This evidence concerns the gene TERT and cancer.